Parade on MSN6d
'I Was Diagnosed With Pulmonary Arterial Hypertension At 25—This Was the First Unexpected Symptom I Experienced'Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...
Riociguat is generally safe and effective for PAH patients with coexisting cardiac and metabolic conditions, a trials ...
Regarded mostly as a lung disease, PAH is often in people with fewer nail fold capillaries, suggesting a disease of the small ...
In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...
GlobalData on MSN1d
Tectonic Therapeutic reports findings from Phase Ia trial of TX45The trial results indicated minimal adverse events and no evidence of immune-mediated clearance following TX45 treatment.
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...
In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...
Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...
Chronic High Blood Pressure During Pregnancy ... This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading ...
BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...
Matt Gline is back with a new ‘vant’ company, after the Roivant Sciences CEO paid Bayer $14 million upfront for the rights to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback